Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Biotech
Celcuity's breast cancer combo hits goals, teeing up FDA filing
The trial hit its primary endpoints, blasting past the biotech’s bar for success to tee up a filing for FDA approval in the fourth quarter.
Nick Paul Taylor
Jul 28, 2025 6:00am
FDA clears Clairity's 5-year breast cancer risk prediction tool
Jun 5, 2025 1:00pm
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am
AstraZeneca's breast cancer pill boosts PFS by 56% in phase 3
Jun 2, 2025 7:10am
Arvinas lays off 33% of staff, axes Pfizer-partnered trials
May 1, 2025 8:50am
Study illustrates pros, cons of AI readings in 3D mammography
Apr 25, 2025 12:00pm
